FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 16228240 · Received January 23, 2023

Report

Report Number
3011299751-2023-00009
Event Type
Injury
Date Received
January 23, 2023
Date of Event
November 10, 2022
Report Date
January 23, 2023
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
UDI-DI
10888628032439
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). ARTICLE CITATION: CREAGMILE J, KIM WI, SCOUARNEC C. HYDRUS MICROSTENT IMPLANTATION WITH OMNI SURGICAL SYSTEM AB INTERNO CANALOPLASTY FOR THE MANAGEMENT OF OPEN-ANGLE GLAUCOMA IN PHAKIC PATIENTS REFRACTORY TO MEDICAL THERAPY. AM J OPHTHALMOL CASE REP. 2022 NOV 10;29:101749. DOI: 10.1016/J.AJOC.2022.101749. PMID: 36544749; PMCID: PMC9762144. MULTIPLE REQUESTS FOR FURTHER INFORMATION HAVE BEEN MADE. ALLERGAN HAS RECEIVED NO RESPONSE FROM THE AUTHORS. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT.

Description of Event or Problem · 0

REPORTED EVENTS OF "XEN 45 GEL STENT IMPLANTATION THAT FAILED DESPITE BLEB NEEDLING REQUIRING AN AHMED VALVE, WHICH LATER FAILED. THE PATIENT WAS TAKING 4 MEDICATIONS (BRIMONIDINE, DORZOLAMIDE/TIMOLOL, LATANOPROST) WITH AN IOP OF 29 MMHG. THEY THEN UNDERWENT IMPLANTATION OF TWO HYDRUS MICROSTENTS WITH OMNI SURGICAL SYSTEM CANALOPLASTY." WERE NOTED IN THE ARTICLE: HYDRUS MICROSTENT IMPLANTATION WITH OMNI SURGICAL SYSTEM AB INTERNO CANALOPLASTY FOR THE MANAGEMENT OF OPEN-ANGLE GLAUCOMA IN PHAKIC PATIENTS REFRACTORY TO MEDICAL THERAPY. AM J OPHTHALMOL CASE REP. 29:101749. THIS IS THE SAME ARTICLE REPORTED UNDER MDR REPORT # 3011299751-2023-00008 (ALLERGAN COMPLAINT # (B)(4). THIS MDR IS BEING SUBMITTED FOR THE CASE 6.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
484216 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) 5513-001 NI 10888628032439

Patients

Seq Age Sex Outcome Treatment
1 55 YR Male Required Intervention